POSTER SESSION V
Wednesday, March 21, 2012 — 9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
188
Nodal Involvement by Transformed Cutaneous CD30-Positive T-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma
(1556)
JY Song, FC Eberle, L Xi, M Raffeld, NL Harris, WH Wilson, S Pittaluga, ES Jaffe - NCI, Bethesda, MD; Massachusetts General Hospital and Harvard Medical School, Boston, MA
Phospho-STAT3 Is Active in the Majority of Anaplastic Large Cell Lymphomas with ALK Translocation
(1527)
R Rawson, R Alsabeh, S Alkan - Cedars-Sinai Medical Center, Los Angeles, CA
Breast Implant Associated ALCL Closely Resembles Primary Cutaneous ALCL
(1448)
ME Kadin, H Xu, I Pavlov, AL Epstein - Roger Williams Med Ctr, Providence, RI; U. Utah, Salt Lake City, UT; USC, Los Angeles, CA
Subcutaneous Panniculitis-Like T-Cell Lymphoma in Children
(1433)
AR Huppmann, S Pittaluga, M Raffeld, L Xi, ES Jaffe - National Institutes of Health/National Cancer Institute, Bethesda, MD
Foxp3 Is Differentially Expressed in Morphological Variants of US/Caribbean Adult T-Cell Leukemia/Lymphoma
(1601)
J Yao, SRS Gottesman, A Braverman, CA Axiotis - SUNY Downstate Medical Center, Brooklyn, NY; Kings County Hospital Center, Brooklyn, NY
Impact of FTY720 on S1PR1-Positive HTLV-1-Infected T-Cell Lines
(1533)
Y Sadahira, H Fujiwara, H Nishimura, T Akiyama, I Irei, S Hamazaki - Kawasaki Medical School, Kurashiki, Japan
Analysis of microRNA Expression Profile in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified Shows Diagnostic Potential, and Utility for Predicting Therapeutic Response and Prognosis
(1499)
S-J Nam, YK Jeon, CW Kim - Seoul National University College of Medicine, Seoul, Korea
Angioimmunoblastic T-Cell Lymphoma with Hyperplastic Germinal Centres (Pattern 1) Assumes Conventional, Geographic, Floral and Progressively Transformed Variants Unified by Superior Survival, Unassociated with Secondary B-Lineage Lymphomas, Compared to Patterns 2 and 3 — A Meta-Analysis of 56 Cases
(1567)
LHC Tan, SY Tan, T Tang, ST Lim, DCL Tan - Singapore General Hospital, Singapore; National Cancer Centre, Singapore
Primary CNS T-Cell Lymphomas: Clinical, Morphologic, Immunophenotypic and Molecular Analysis
(1491)
MP Menon, A Jegalian, M Raffeld, S Pittaluga, L Xi, ES Jaffe - National Cancer Institute/National Institute of Health, Bethesda, MD; Cleveland Clinic, Cleveland, OH
Clinicopathologic Study of Mature T-Cell Lymphoma with B-Cell Markers: A Review of 21 Cases
(1384)
F Climent, S Pittaluga, D Martinez, E Gonzalez-Barca, V Romagosa, M Raffeld, E Campo, ES Jaffe - Hospital de Bellvitge, L´Hospitalet de Llobregat, Barcelona, Spain; National Cancer Institute, NIH, Bethesda, MD; Hospital Clinic, Barcelona, Spain; Institut Català d´Oncologia, L´Hospitalet de Llobregat, Barcelona, Spain
Structural Abnormalities of JAK2 in Peripheral T-Cell Lymphomas
(1399)
AL Feldman, G Vasmatzis, SH Johnson, RP Ketterling, RA Knudson, SM Ansell, A Dogan, ME Kadin - Mayo Clinic, Rochester, MN; Roger Williams Medical Center, Providence, RI
Flow Cytometric Evaluation of Programmed Death-1 (PD1) in Benign and Neoplastic Lymphoid Proliferations
(1408)
KJ Garner, SP TenEyck, SH Swerdlow, RE Felgar - University of Pittsburgh, Pittsburgh, PA
Cytopenia Associated with Abnormal T-Cell Response
(1575)
J Tong, S Lu, NG Haycocks, RY Zhao, SA Stass, XF Zhao - University of Maryland School of Medicine, Baltimore, MD
HIV-Associated Hodgkin Lymphoma in African-Americans
(1437)
KM Irrinki, O Ajayi, L Fitzpatrick, A Aggarwal, L Taddesse- Heath - Howard University Hospital and College of Medicine, Washington, DC
Glioma-Associated Oncogene Homologue 3, a Hedgehog Transcription Factor, Contributes to the Classical Hodgkin Lymphoma Microenvironment through the Modulation of a Subset of Inflammatory Chemokines and Cytokines
(1351)
K Alayed, K Kunkalla, C Qu, Z Chakhachiro, LJ Medeiros, R Singh, F Vega - MD Anderson Cancer Center, Houston
The Presence of Langerhans Cells Is Positively Correlated with the Extent of Eosinophilia in Classical Hodgkin Lymphoma
(1576)
EE Torlakovic, G Young, C Cheung, S Dirnhofer, A Tzankov - University Health Network/University of Toronto, Toronto, Canada; Institute for Pathology/University of Basel, Basel, Switzerland
Tumor-Associated Macrophages Predict Inferior Outcomes in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma – A Correlative Study from the E2496 Intergroup Trial
(1568)
KL Tan, DW Scott, F Hong, SJ Horning, RI Fisher, NL Bartlett, LE Shepherd, JM Connors, BS Kahl, LI Gordon, C Steidl, RD Gascoyne - British Columbia Cancer Agency, Vancouver, Canada; Dana Farber Cancer Institute, Boston; Genentech, Inc, South San Francisco; University of Rochester, Rochester; Washington University, St. Louis; NCIC Clinical Trials Office, Kingston, Canada; University of Wisconsin, Madison; Northwestern University, Chicago
Microenvironment in Nodular Lymphocyte Predominant Hodgkin Lymphoma, Classical Hodgkin Lymphoma and T-Cell/Histiocyte Rich Large B-Cell Lymphoma: An Immunohistochemical Comparison
(1520)
S Prakash, Y-C Liu, DM Knowles, A Orazi, W Tam - Weill Cornell Medical College, New York
Evaluation of Lymphocyte Subsets of Nodular Lymhocyte Predominant Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and T Cell/Histiocyte-Rich Large B-Cell Lymphoma by Flow Cytometry
(1404)
JR Fromm, D Wu - University of Washington, Seattle, WA
Identification of Novel Antigens To Identify the Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma Using a Lyoplate
(1405)
JR Fromm, D Wu, BL Wood - University of Washington, Seattle, WA
Epstein-Barr Virus-Associated Splenic Mesenchymal Tumor – A Proposal of Comprehensive Tumor Entity
(1493)
T Mitsuhashi, Y Hatanaka, K Kubota, T Hasegawa, T Takahashi, Y Matsuno - Hokkaido University Hospital, Sapporo, Hokkaido, Japan; Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan; Kushiro Rosai Hospital, Kushiro, Hokkaido, Japan
Flow Cytometric Analysis of Fine Needle Aspirates Is Affected by Tumor Subtype
(1579)
CJ VandenBussche, SZ Ali, KH Burns, CD Gocke, M Vuica- Ross, MJ Borowitz, AS Duffield - Johns Hopkins Medical Institutions, Baltimore, MD
Automated Image Analysis and Scoring of Tartrate Resistance Acid Phosphatase Preparations
(1389)
B Dangott, M Salama - University of Utah, Salt Lake City, UT
Detection of Malignant Epithelial Cells in Body Fluids: A Comparison of Flow Cytometry and Cytologic Evaluation
(1495)
HD Morris, NJ Karandikar, J Balani, F Fuda, S Monaghan, J Emmons - UT Southwestern Medical Center, Dallas, TX
Significant Increase in Cadaveric Renal Transplants in Highly Sensitized Patients by Implementing Virtual Crossmatch: A Unicenter Experience
(1490)
S Mehendale, B Labuda, A Jaramillo, S Gaitonde - University of Illinois at Chicago, Chicago, IL; Histocompatibility Laboratory, Gift of Hope Organ & Tissue Donor Network, Itasca, IL
A Novel Nanofluidics-Based Single-Platform Molecular Testing Approach for Chronic Myelogeneous Leukemia (CML)
(1416)
WO Greaves, S Verma, KP Patel, R Singh, NG Reddy, R Giffard, S Hai, H Yao, L Shen, LJ Medeiros, R Luthra - The University of Texas MD Anderson Cancer Center, Houston, TX
Isolated Clonal Trisomy 13 in Philadelphia Chromosome- Negative Metaphases in Patients with Chronic Myelogenous Leukemia
(1602)
CC Yin, S Hu, LJ Medeiros, G Lu - UT MD Anderson Cancer Center, Houston, TX
Loss of BCR-ABL PCR-Negativity Predicts an Increased Risk of Subsequent Molecular, Cytogenetic and Hematologic Relapse in CML Patients Treated with Tyrosine Kinase Inhibitors
(1484)
MH Luu, CB Rempfer, RD Press - Oregon Health and Science University, Portland, OR
Dasatinib Affects Bone Homeostasis, Independent of Molecular Response, in Patients with Chronic Myelogenous Leukemia (CML)
(1424)
D Hoehn, N Pemmaraju, JE Cortes, X Wang, R Kanagal- Shamanna, SE Dellasala, A Nazha, HM Kantarjian, LJ Medeiros, CE Bueso-Ramos - UT MD Anderson Cancer Center, Houston, TX
Blast Phase in Chronic Myelogenous Leukemia (CML) Is Skewed towards Unusual Blast Types in Patients Treated with Tyrosine Kinase Inhibitors (TKIs): A Comparative Study of 67 Cases
(1525)
A Rand, J Crow, JO Moore, AS Lagoo - Duke University Medical Center, Durham, NC
Aberrant Expression of CD56 on Granulocytes and Monocytes in Myeloproliferative Neoplasm and Myelodysplastic Syndrome
(1412)
P Gong, F Metrebian, A Dulau-Florea, Z-X Wang, R Bajaj, SC Peiper, JZ Gong - Thomas Jefferson University Hospital, Philadelphia, PA; Academia Nacional de Medicina, Buenos Aires, Argentina
Potential Role of Altered Megakaryocyte CD31 Expression in Myeloproliferative Neoplasms (MPNs)
(1480)
AA Lo, A Chiu, E Hyjek, J Wilson, A Chadburn - Northwestern University, Chicago, IL; Brigham and Women´s Hospital, Boston, MA; University of Chicago, Chicago, IL
Mean Platelet Volume Aids in the Differential Diagnosis of Chronic Myeloproliferative Neoplasms
(1400)
JL Frater, CS Eby - Washington University School of Medicine, St Louis, MO
Evaluation of Platelet Morphology in Peripheral Blood Smear Is a Simple but Very Useful Tool for Prediction of Primary Myelofibrosis
(1589)
J Wayne, S Kitahara, S Alkan - Cedars-Sinai Medical Center, Los Angeles, CA
TP53 Mutation Is Rare in Primary Myelofibrosis by High Resolution Melting Curve Analysis and Sanger Sequencing
(1415)
WO Greaves, S Verma, T Bisrat, H Rahimi, A Paladugu, H Yao, KP Patel, R Luthra, LJ Medeiros, S Verstovsek, CE Bueso-Ramos - The University of Texas MD Anderson Cancer Center, Houston, TX
Bone Marrow Histology and Red Cell Mass Allow Accurate Identification of Early Stage Polycythemia Vera
(1507)
A Orazi, L Boiocchi, W Chow, K Vandris, I Tam, A Narayan, MT De Sancho, W Tam, Y Wu, Y-C Liu, SJ Goldsmith, RT Silver - Weill Cornell Medical College, New York, NY
Differential Expression of Activation-Related Antigens on Masts Cells and Eosinophils in Patients with Systemic Mastocytosis and Hypereosinophilic Syndrome
(1548)
O Simakova, T Wilson, M Wang, N Olivares, A Klion, DD Metcalfe, I Maric - NIH, CC, Bethesda, MD; NIH, NIAID, Bethesda, MD
Loss of CD25 Expression in Advanced Systemic Mastocytosis Patients Treated with Midostaurin (PKC412)
(1462)
CA Kunder, DJ Deangelo, JR Gotlib, G Gitana, SK Atwater, TI George - Stanford University, Stanford, CA; Dana-Farber Cancer Institute, Boston, MA
Treatment-Related Myeloid Neoplasms Secondary to Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL): A Clinicopathologic Study of 8 Cases
(1563)
MM Stoecker, Q Huang, EL Boswell, E Wang - Duke University Medical Center, Durham, NC; City of Hope Medical Center, Duarte, CA
Spectrum of Immunophenotypic Aberrancies in Myelomonocytic Antigens in Chronic Myelomonocytic Leukemia: Novel Identification of CD11c Underexpression
(1554)
P Sojitra, P Gandhi, Y Li, G Venkataraman - Loyola University Medical Center, Maywood, IL
Myelodysplastic and Myeloproliferative Subtypes of Chronic Myelomonocytic Leukemia Display Distinct Morphologic and Immunophenotypic Features
(1363)
L Boiocchi, N Di Lorenzo, F Savi, A Fargnoli, A Orazi, U Gianelli - Weill Cornell Medical College, New York, NY; Universita´ di Milano, IRCCS Ca´ Granda-Ospedale Maggiore Policlinico, Milano, Italy
Can We Refine Diagnostic Criteria for Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis (RARST)?
(1531)
HJ Rogers, V Visconte, RV Tiu, JP Maciejewski, ED Hsi - Cleveland Clinic, Cleveland, OH
button next to any title to add to Itinerary Planner...
Add
